topotecan has been researched along with Lymphoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lei, Q; Tang, SQ; Wang, TY | 1 |
| Yamanaka, R | 1 |
| Ames, M; Bonner, W; Carter, J; Chen, A; Doroshow, JH; Hollingshead, M; Ji, J; Jia, L; Kinders, R; Kummar, S; Melillo, G; Murgo, AJ; Parchment, RE; Pommier, Y; Reid, JM; Rubinstein, L; Speranza, G; Stotler, H; Tomaszewski, JE; Wang, L; Weil, M; Zhang, Y | 1 |
| D'Orazio, A; Gibson, AD | 1 |
| Bhalla, K; Blaskovich, MA; Dunne, J; Gasparetto, M; Gentry, T; Haaland, P; Nimmanapalli, R; O'Bryan, E; Rizzieri, D; Sebti, S; Smith, C | 1 |
| Pavlidis, N; Pentheroudakis, G | 1 |
| Birkmann, J; Fischer, L; Jahnke, K; Klasen, HA; Korfel, A; Martus, P; Thiel, E | 1 |
| Coutinho, F; Dantas, AA; Del Giglio, A; Manhani, AR | 1 |
| Weller, M | 1 |
| Adams, DJ; Giles, F; Jacobsen, TF; Myhren, F; Rizzieri, DA; Sandvold, ML | 1 |
| Smart, T | 1 |
2 review(s) available for topotecan and Lymphoma
| Article | Year |
|---|---|
[Medical management of primary central nervous system lymphoma refractory or resistant to standard of care treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dacarbazine; Drug Discovery; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Rituximab; Salvage Therapy; Temozolomide; Topotecan | 2009 |
Management of leptomeningeal malignancy.
Topics: Adenocarcinoma; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Arachnoid Cysts; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Delayed-Action Preparations; Enzyme Inhibitors; Humans; Injections, Intravenous; Injections, Spinal; Leukemia; Lymphoma; Meningeal Neoplasms; Methotrexate; Palliative Care; Randomized Controlled Trials as Topic; Thiotepa; Topoisomerase I Inhibitors; Topotecan | 2005 |
3 trial(s) available for topotecan and Lymphoma
| Article | Year |
|---|---|
Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Drug Administration Schedule; Female; Humans; Lymphoma; Male; Maximum Tolerated Dose; Mice; Mice, Nude; Middle Aged; Neoplasms; Poly(ADP-ribose) Polymerases; Topoisomerase I Inhibitors; Topotecan; Xenograft Model Antitumor Assays | 2011 |
Prospective trial on topotecan salvage therapy in primary CNS lymphoma.
Topics: Adult; Aged; Antineoplastic Agents; Central Nervous System Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Topotecan | 2006 |
Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Analysis; Topotecan | 2006 |
6 other study(ies) available for topotecan and Lymphoma
| Article | Year |
|---|---|
[Effect of topotecan on MAGE gene expression of HPB-AM cells].
Topics: Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression; Humans; Lymphoma; Neoplasm Proteins; RNA, Messenger; Topotecan | 2009 |
VIII International Conference on malignant lymphoma. June 12-15, 2002 Lugano, Switzerland.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Lymphoma; Lymphoma, Mantle-Cell; Middle Aged; Paclitaxel; Prednisone; Rituximab; Time Factors; Topotecan; Treatment Outcome; Vincristine | 2002 |
Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Aphidicolin; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Lymphoma; Phenanthrolines; Rituximab; Topotecan | 2004 |
[Chemotherapy for brain tumors in adult patients].
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Combined Modality Therapy; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Genetic Markers; Glioma; Humans; Lymphoma; Prognosis; Promoter Regions, Genetic; Temozolomide; Topotecan; Tumor Suppressor Proteins | 2008 |
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cytarabine; Deoxycytidine; Drug Interactions; Drug Screening Assays, Antitumor; Gemcitabine; Humans; Hydrazines; Idarubicin; Irinotecan; Leukemia; Lymphoma; Sulfonamides; Topotecan | 2008 |
Topotecan research moves forward at last.
Topics: Antineoplastic Agents; Antiviral Agents; Camptothecin; Clinical Trials as Topic; HIV Long Terminal Repeat; HIV-1; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma; Mutation; Sarcoma, Kaposi; Topoisomerase I Inhibitors; Topotecan; Virus Replication | 1995 |